Pennsylvania Adult-Use Stalled, Medical Program Strong
Key Questions
Why did Pennsylvania's adult-use legalization effort stall?
HB20 stalled in the Senate and the state budget deal explicitly excluded adult-use legalization and taxation, leaving a $2.4B revenue gap. Governor Shapiro signed the $50.8B compromise budget without cannabis provisions.
How strong is Pennsylvania's medical marijuana program?
The program remains robust with $9.1B in cumulative sales, 438,000 patients, and 192 dispensaries. First-half 2026 sales reached $922M, up 5.2% year-over-year.
What are the prospects for future legalization in Pennsylvania?
A new bill is pending that could add medical marijuana benefits and protections. Public support stands at 74-75%, though the gubernatorial race features a pro-legalization incumbent versus a potential veto opponent.
HB20 and adult-use legalization remain stalled, and the 2026 budget excluded recreational cannabis despite Gov. Shapiro’s projected tax revenue. Pennsylvania’s medical market recorded about $116 million in July sales and 438,000 patients, while Cresco’s reported acquisition of nine dispensaries demonstrates continued consolidation; the governor’s race and intoxicating-hemp rules remain key variables.